Valuation: BioNexus Gene Lab Corp.

Market Cap 4.08M 3.59M 3.39M 3.08M 5.78M 391M 5.81M 40.6M 15.68M 200M 15.31M 14.98M 642M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value 263K 232K 219K 199K 373K 25.27M 375K 2.62M 1.01M 12.9M 989K 967K 41.44M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
55.28%
Yield 2024 *
-
Yield 2025 -
1 day-6.47%
1 week-13.33%
Current month-12.75%
1 month-16.13%
3 months-35.96%
6 months-43.96%
Current year-67.09%
1 week 1.25
Extreme 1.2534
1.5
1 month 1.25
Extreme 1.2534
1.61
Current year 1.07
Extreme 1.07
4.14
1 year 1.07
Extreme 1.07
5.89
3 years 1.07
Extreme 1.07
33.9
5 years 1.07
Extreme 1.07
270
10 years 1.07
Extreme 1.07
414
Manager TitleAgeSince
Chief Executive Officer 43 10/12/2023
Director of Finance/CFO 63 16/06/2025
Director TitleAgeSince
Director/Board Member 71 06/03/2022
Director/Board Member 43 10/12/2023
Director/Board Member 51 10/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Free

Director

32,258 1.0997%
13/08/26 Free

Chief Executive Officer

338,709 11.5465%
13/08/26 Free

Director

16,129 0.5498%
Change 5-day change 1-year change 3-year change Capi.($)
-6.47%-13.33%-76.23%-85.06% 4.08M
+2.64%+7.07%+11.87%+38.40% 47.97B
+0.22%+0.40%+49.94%+37.06% 44.5B
-1.58%+4.66%+337.90%+614.38% 43.93B
+1.70%+0.36%+10.27%+99.27% 41.03B
+0.51%-0.61%+5.18%+46.87% 29.85B
-0.48%-1.32%+23.00%+150.01% 17.27B
+0.08%+9.03%+8.29% - 15.34B
+1.76%+2.98%+29.13%+45.78% 15.3B
+1.97%-3.17% - - 14.82B
Average -0.03%+0.92%+44.37%+118.34% 27B
Weighted average by Cap. +0.68%+2.89%+75.16%+163.61%

Financials

2024 2025
Net sales 9.51M 8.36M 7.91M 7.17M 13.47M 913M 13.55M 94.71M 36.58M 466M 35.71M 34.93M 1.5B 7.42M 6.53M 6.18M 5.6M 10.52M 713M 10.58M 73.94M 28.55M 364M 27.88M 27.27M 1.17B
Net income -1.6M -1.41M -1.33M -1.21M -2.26M -153M -2.28M -15.92M -6.15M -78.29M -6M -5.87M -252M -2.98M -2.62M -2.48M -2.25M -4.23M -286M -4.25M -29.72M -11.48M -146M -11.21M -10.96M -470M
Net Debt -4.15M -3.65M -3.45M -3.13M -5.88M -398M -5.91M -41.32M -15.96M -203M -15.58M -15.24M -653M -3.81M -3.35M -3.17M -2.88M -5.4M -366M -5.43M -37.98M -14.67M -187M -14.32M -14.01M -600M
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
28/09/26 US$1.300 -6.47% 11,357
25/09/26 US$1.390 -6.08% 6,039
24/09/26 US$1.480 +0.68% 3,106
23/09/26 US$1.470 +0.68% 3,341
22/09/26 US$1.460 -2.67% 1,997
  1. Stock Market
  2. Stocks
  3. BGLC Stock